EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The epidemiology of intestinal protozoa in the Israeli population based on molecular stool test: a nationwide study

Avi Peretz iD, Maya Azrad iD, Shifra Ken-Dror, Merav Strauss, Dana Sagas, Miriam Parizada, Shulamit Loewnthal, Doron Amichay, Nili Ben Horin, Yotam Shenhar, Orli Sagi, Elina Bazarsky und 2 weitere

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00616-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Avi Peretz und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Israel, Sa…. Hauptthemen laut MEDLINE: Feces, Intestinal Diseases, Parasitic, Giardia lamblia, Cryptosporidium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stool examination using microscopy was the traditional method for the diagnosis of intestinal parasites. Recently, the use of molecular tests to identify stool protozoa has become the main tool used in most clinical laboratories in Israel. This study aimed to evaluate the prevalence of intestinal parasites in Israel and to compare this prevalence in laboratories that use molecular tests vs a laboratory that uses microscopy. Samples collected from January to October 2021 at seven laboratories were analyzed by real-time PCR (RT-PCR) or by microscopy. The multiplex panel included the following pathogens: Giardia lamblia , Entamoeba histolytica , Cryptosporidium spp. , Cyclospora , Dientamoeba fragilis , and Blastocystis spp . Overall, 138,415 stool samples were tested by RT-PCR and 6,444 by microscopy. At least one protozoa species was identified in 28.4% of the PCR-tested samples compared to 4.6% of the microscopy-tested samples. D. fragilis was the most common PCR-identified species (29%). D. fragilis , G. lamblia , and Cryptosporidium spp . were mainly found in pediatric population, while Blastocystis spp . was most prevalent among adults ( P < 0.001). In a sub-cohort of 21,480 samples, co-infection was found in 4,113 (19.15%) samples, with Blastocystis spp . and D. fragilis being the most common (14.9%) pair. Molecular stool testing proved more sensitive compared to microscopy. D. fragilis was the most commonly detected pathogen. The above profile was identified during the COVID pandemic when traveling was highly restricted and most likely represents the locally circulating protozoa. IMPORTANCE This study sheds light on the prevalence of stool parasites in Israel. Additionally, this study indicates that the shift from microscope analysis to molecular tests improved protozoa diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesIntestinal Diseases, ParasiticGiardia lambliaCryptosporidiumHumansIsraelChildChild, PreschoolAdultAdolescentMiddle AgedFemaleMaleInfantYoung AdultAgedPrevalenceBlastocystisProtozoan InfectionsDientamoebaEntamoeba histolyticaReal-Time Polymerase Chain ReactionInfant, NewbornAged, 80 and over

Stichwörter der Autor:innen

Blastocystis sppD. fragilisE. histolyticaG. lambliaIsraeli populationintestinal protozoamultiplex RT-PCRstool microscopy analysis

Autor:innen und Institutionen

  • Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Israel, Safed.
  • The Azrieli Faculty of Medicine, Bar Ilan University, Safed, Tiberias, Israel.
  • Clinical Microbiology Laboratory, Central Laboratories Haifa and Western Galilee, Clalit Health Services, Nesher, Israel.
  • Clinical Microbiology Laboratory, Emek Medical Center, Clalit Health Services, Afula, Israel.
  • Maccabi Health Services, Central Laboratories, Rehovot, Israel.
  • Central Laboratories, Clalit Health Services, Tel Aviv, Israel.

ORCID-Profile: Avi Peretz, Maya Azrad

Zitieren

APA

Peretz, A., Azrad, M., Ken-Dror, S., Strauss, M., Sagas, D., Parizada, M., Loewnthal, S., Amichay, D., Ben Horin, N., Shenhar, Y., Sagi, O., Bazarsky, E., Amit, S., & Schwartz, E. (2024). The epidemiology of intestinal protozoa in the Israeli population based on molecular stool test: a nationwide study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00616-24

Vancouver

Peretz A, Azrad M, Ken-Dror S, Strauss M, Sagas D, Parizada M, et al. The epidemiology of intestinal protozoa in the Israeli population based on molecular stool test: a nationwide study. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00616-24

BibTeX
@article{Peretz2024,
  author = {Peretz, Avi and Azrad, Maya and Ken-Dror, Shifra and Strauss, Merav and Sagas, Dana and Parizada, Miriam and Loewnthal, Shulamit and Amichay, Doron and Ben Horin, Nili and Shenhar, Yotam and Sagi, Orli and Bazarsky, Elina and Amit, Sharon and Schwartz, Eliezer},
  title = {The epidemiology of intestinal protozoa in the Israeli population based on molecular stool test: a nationwide study},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00616-24}
}
Kostenlos starten →